Practices

Cases Investigated

Beasley Allen is currently investigating cases involving prescription drugs. However, our attorneys would like to investigate any claims of serious injury or death that may be the result of defective medical devices or drugs.

Johnson & Johnson, Janssen Pharmaceuticals legal battles over Risperdal continue

March 15, 2017 - Plaintiffs contend Janssen concealed the risk of Risperdal’s most devastating side effect, gynecomastia, or the abnormal growth of breast tissue in young boys. Read More


Bristol-Myers Squibb top-selling antipsychotic Abilify linked to users’ compulsive gambling

March 8, 2017 - When the FDA reviewed Abilify’s adverse events reports, 184 of them linked the drug with the impulse-control problems that developed in adults and children taking Abilify. The most... Read More


Lawsuits increase as research linking Proton Pump Inhibitor (PPI) heartburn drugs and kidney damage mounts

March 1, 2017 - A 1992 study first linked PPI use to Acute Interstitial Nephritis (AIN), inflammation in the spaces between the kidney tubules. Later studies linked PPI use with an increased risk of Acute... Read More


First Xarelto trial set for April; blood thinner linked to severe bleeding risk

February 24, 2017 - The first of four bellwether trials for the Xarelto multidistrict litigation (MDL) is set to begin on April 24, 2017 in the Eastern District of Louisiana. Read More


J&J and Jansen Pharmaceuticals look to expand uses for Invokana despite growing lawsuits

February 16, 2017 - Researchers have tracked additional data about patients’ renal outcomes as a result of Invokana's link to a number of serious renal-impairing side effects including diabetic ketoacidosis... Read More


Beasley Allen lawyer Danielle Mason selected to help lead Invokana MDL

January 25, 2017 - Danielle Ward Mason, the firm’s leading Invokana attorney, has been appointed to serve on the Plaintiffs’ Steering Committee for Invokana multidistrict litigation. Read More




Diabetes drug Invokana linked to ketoacidosis

September 30, 2016 - Invokana, which contains the drug ingredient canagliflozin, was approved by the Food and Drug Administration (FDA) in March 2012. Read More


Possible serious side effects of PPI heartburn drugs include increased risk of kidney disease

June 29, 2016 - The research looked at the treatment of nearly 200,000 patients for more than five years and found approximately 20 percent higher risk of kidney disease in PPI users. Read More


back to top